Delivering Actionable Genomic Insights for Tangible Patient Cognition Results
Cognitive Decline Treatment Led by Genomics Decision Support Software
With 2 out of 3 Americans expected to experience some form of cognitive impairment, with symptoms often starting as early as age 50, clinicians are faced with the critical task of treating patients concerned about memory preservation and avoiding cognitive decline. Amidst this challenge, IntellxxDNA surfaces as a groundbreaking resource. Highlighted in a research study by the Frontiers in Aging Neuroscience journal, IntellxxDNA’s profound impact on identifying and addressing cognitive decline is clearly demonstrated. This pioneering tool is shaping the future of personalized medicine, providing actionable genomic insights to effectively mitigate cognitive decline and improve patient outcomes.
IntellxxDNA & Your Practice
Save Time & Money
Save time and money with each patient interaction by being able to find and treat root causes based on genomics.
Confidence in Decisions
Research in our database is unbiased, significant, and scientifically supported.
Real & Personalized Results
Join countless physicians using genomically targeted personalized medicine to treat the root causes of patient problems.
Exceptional Levels of Care for All
With detailed discussions of over 700 SNPs and 10,000 references, you’ll be able to deliver Molecular-level healing to a variety of patients.
The IntellxxDNA Clinical Decision Support Tool
With detailed discussions of over 700 SNPs and over 10,000 references, our clinical decision support software provides comprehensive, accessible medical reports and scientific explanations of specific genomic patient data. IntellxxDNA puts the world of medical genomics research and functional medicine interventions at your fingertips
What Sets Us Apart
Accuracy and Integrity of Research
Released only to licensed health care professionals, our reporting and analytics follow strict guidelines that ensure only studies with good scientific evidence and appropriate confidence levels are included. Utilizing our proprietary analytical methodology, IntellxxDNA provides clinicians with unbiased, scientifically current data reflecting potential additive risks and benefits that are clinically significant and scientifically supported.
The Convergence of Traditional, Functional and Integrative Medicine
Our personalized reports help clinicians understand gene function and explore potential prevention and intervention strategies. One key feature of our reports is our detailed discussions of potential interventions, which include elements from integrative and functional medicine as well as traditional medicine. Clinical reports are divided into health risk and benefit categories, where genomic single nucleotide polymorphisms (SNPs) are grouped to show risks and benefits. As a Clinical Decision Support Tool, IntellxxDNA gives you enough information about potential interventions, including information about supplement mechanisms, studies and dosing, so that you can truly develop informed, targeted plans.
Explore IntellxxDNA with a Personalized Tour
Receive a concise overview of the IntellxxDNA genomic tool, including an interactive demo, training details, a preview of 2-3 specific topics (like anxiety, Alzheimer’s SNPs, etc.), and implementation examples for your practice.
Common Questions
Below are the answers to the questions we hear most from clinicians.
Want to know more? Contact info@intellxxdna.com for assistance.
I want to know more about the integrity of your research.
Released only to licensed health care professionals, our reporting and analytics follow strict guidelines that ensure only studies with good statistical data, reproducibility and appropriate confidence intervals are included. IntellxxDNA™ provides clinicians with highly accurate data reflecting potential additive risks information utilized in the development of IntellxxDNA™ reports comes from peer reviewed studies in the published medical literature. We aim to include only information of the highest clinical significance which is scientifically proven and supported by highly significant p values.
Genomic analysis can be complex and lengthy. Our reports focus on significant results and present the results in a format that allows clinicians to easily access data. All SNPs and other information within our reports including potential intervention and prevention strategies for addressing SNPs are referenced, so that you as a clinician can easily review any articles of interest and confirm our findings.
I want to know about your genomic reports.
For many health care professionals, two barriers to entry into utilizing genomic intelligence are time and complexity. IntellxxDNA™ reports distill dense information into an organized, color-coded structure to facilitate ease of use. Each result provides the clinician with scientific explanations and well-researched, evidence-based potential intervention strategies to support clinical decision-making.
We invite you to schedule a personalized tour with us to review a Sampler Report.
The field of genomics is complex and quickly evolving. How do you support clinician training?
IntellxxDNA™ has training video modules and other materials in development that our clinicians may access. These instructional support tools are designed to expand their knowledge base regarding gene function and implication within potential interventions. Topics include:
- Genomic Consultation Topics and Best Practices
- Safety Considerations
- Genomics Overview
- Disease State Spotlights: Modules focused on gene function, and potential preventions/interventions, within specific, complex disease states.
- Cognition and other case studies to show you IntellxxDNA™ reports in action.
Help me understand differences in genomic tests.
Direct-To-Consumer Genotype Tests
You may have seen commercials for companies that provide DNA tests and health reports to the general public, often piggybacking on the public’s interest in genealogy and ancestry. We appreciate that their marketing efforts have brought the concept of genomics and health into the public eye, however the tests and reports that they deliver to the public are not medically comprehensive. These tests only show variants relayed through selected, single SNPs, which don’t tell the whole story from a clinical perspective.
Commercial Exome Tests
Some companies conduct whole genomic or exome sequencing – meaning they sequence all of your genes. Exome sequencing is a good choice if you are looking for a rare genetic illness, and you need to identify very large deletions or insertions. Examples of genetic illnesses include Huntington’s disease or genetic forms of breast cancer (i.e. BRCA). However, current exome reports do not tend to highlight gene interactions, role of variants, or potential modulation strategies. They are also cost prohibitive for routine use.
IntellxxDNA™ Clinical Tests & Analytic Reports
Created by clinicians for clinicians, IntellxxDNA™ is a clinical decision support tool that provides genomic data and analytics based on gene-to-gene and gene-to-environment interactions through SNP technology.
Whereas most commercial tests focus on just a few alleles or single SNPs, our technology and proprietary methodology dives into the interplay within multiple SNPs, as well as the role that minor alleles play in gene function. IntellxxDNA™’s reporting provides analytics on SNP variables and pairs these findings with odds ratios, a critical factor in clinical decision-making.
IntellxxDNA™’s data and analytics look at the complex intricacies of a patient’s genomic profile and how small variations within their DNA affect their quality of life and health risks. We include evidence-based, well-researched potential intervention strategies – encompassing environment, lifestyle, nutrition, supplements and medications. These components make our reports accessible and actionable for ease-of-use in clinical decision-making.
I want to utilize the IntellxxDNA™ clinical decision support tool in my practice. How do I establish an account?
We only offer accounts to licensed health care professionals. To become an IntellxxDNA™ clinician, you will be required to provide proof of licensure. Once approved, you will receive login instructions to your dedicated clinician dashboard. This dashboard will be your portal to your patients' reporting, training and support materials and other information of assistance.
Click here to request a new account.
Or email us at info@intellxxdna.com, and a member of our team will help you establish your account.